Lyrica is reimbursable from this month

Published: 2011-06-07 06:59:00

Updated: 2011-06-07 06:59:00

From June 1, Pfizer’s Lyrica (pregabalin) could be reimbursed by health insurance, as an adjunct therapy for neuropathic pain and partial seizures with or without secondary generalization in cancer patients.

Lyrica is considered to have a low potential for abuse, and a limited dependence liabi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK